Clinical Trials Browser

Phase 1 × OTHER × Hearing × Clear all

NCT07218913 2026-01-26

Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors

Phase 1 Recruiting

Testicular Neoplasms, Seminoma, Hearing Loss

NCT01485731 2015-06-03

Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer

Phase 1 Completed

Adenocarcinoma, Uterine Cervical Neoplasms, Neoplasms